Recombinant Human CD300f/LMIR3 Fc Chimera Protein, CF Summary
Product Specifications
Optimal dilutions should be determined by each laboratory for each application.
| Human CD300f (Tyr16-Leu155) Accession # AAP57942 |
IEGRMD | Human IgG1 (Pro100-Lys330) |
| N-terminus | C-terminus | |
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
2774-LM
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution | Reconstitute at 100 μg/mL in PBS. |
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: CD300f/LMIR3
LMIR3, also known as CD300f, CD300LF, IREM-1, CLM-1, IgSF13, DIgR1, and MAIR-V, is a 50‑60 kDa glycoprotein member of the immunoglobulin superfamily (1). Human LMIR3 consists of a 137 amino acid (aa) extracellular domain (ECD) with one Ig-like V-type domain, a 21 aa transmembrane segment, and a 113 aa cytoplasmic domain that contains multiple immunoreceptor tyrosine-based inhibitory motifs (ITIMs) or ITIM-like sequences (2, 3). Alternate splicing generates additional isoforms that carry substituted C-terminal tails of varying lengths and sequences following the ECD or transmembrane segment (3). Within the ECD, human LMIR3 shares 43% aa sequence identity with mouse and rat LMIR3. LMIR3 is expressed on the surface of dendritic cells, monocytes, granulocytes, and mast cells as well as on acute myeloid leukemia (AML) blasts (2-4). Pervanadate treatment or antibody cross‑linking of LMIR3 induces phosphorylation of tyrosine residues in the cytoplasmic domain and the subsequent recruitment of phosphatases SHIP, SHP-1, SHP-2, and the p85 alpha subunit of PI3K (2, 3, 5, 6). LMIR3 ligation can induce cell death and inhibit signaling through multiple receptors including Fc epsilon RI, LMIR4, SCF R, TLR2, TLR3, and TLR9 (3-8). In contrast, it enhances
TLR4‑mediated signaling/cytokine production in mast cells through association with the activating signaling protein FcR gamma (5). In mouse, a splice variant of LMIR3 (known as DIgR2, with a 7 aa insertion in the ECD) inhibits CD4+ T cell activation and in vivo Th1 and CTL responses (9). LMIR3 is up‑regulated on monocytes surrounding experimentally-induced spinal cord demyelination and functions as a negative regulator of inflammation in the CNS (10).
- Clark, G.J. et al. (2009) Trends Immunol. 30:209.
- Sui, L. et al. (2004) Biochem. Biophys. Res. Commun. 319:920.
- Alvarez-Errico, D. et al. (2004) Eur. J. Immunol. 34:3690.
- Korver, W. et al. (2009) Leukemia 23:1587.
- Izawa, K. et al. (2009) J. Immunol. 183:925.
- Alvarez-Errico, D. et al. (2007) J. Immunol. 178:808.
- Can, I. et al. (2008) J. Immunol. 180:207.
- Izawa, K. et al. (2007) J. Biol. Chem. 282:17997.
- Shi, L. et al. (2006) Blood 108:2678.
- Xi, H. et al. (2010) J. Exp. Med. 207:7.
Citations for Recombinant Human CD300f/LMIR3 Fc Chimera Protein, CF
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
2
Citations: Showing 1 - 2
Filter your results:
Filter by:
-
CD300lf is the primary physiologic receptor of murine norovirus but not human norovirus
Authors: VR Graziano, FC Walker, EA Kennedy, J Wei, K Ettayebi, MS Strine, RB Filler, E Hassan, LL Hsieh, AS Kim, AO Kolawole, CE Wobus, LC Lindesmith, RS Baric, MK Estes, RC Orchard, MT Baldridge, CB Wilen
PLoS Pathog., 2020-04-06;16(4):e1008242.
Species: Human
Sample Types: Whole Cells
Applications: Cell Culture -
A human antithrombin isoform dampens inflammatory responses and protects from organ damage during bacterial infection
Authors: P Papareddy, M Rossnagel, F Doreen Hol, G Kilic, S Veerla, C Naudin, E Smeds, J Westman, I Martinez-M, A Egesten, ME de la More, J Corral, A Linder, A Artoni, M Abbattista, C Novembrino, C Herbert Br, I Martinelli, G Kasetty, H Herwald
Nat Microbiol, 2019-09-23;0(0):.
Species: Human
Sample Types: Recombinant Protein
Applications: Surface Plasmon Resonance (SPR
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human CD300f/LMIR3 Fc Chimera Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human CD300f/LMIR3 Fc Chimera Protein, CF and earn rewards!
Have you used Recombinant Human CD300f/LMIR3 Fc Chimera Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
